Drugs / Methylprednisolone hemisuccinate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02048358 | Nov 2013 → Jan 2015 | multiple sclerosis | BBB-Therapeutics B.V. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Methylprednisolone hemisuccinate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02048358 ↗ |
| Route | Intravenous | “Methylprednisolone hemisuccinate 1000mg, once, IV infusion” NCT02048358 ↗ |